Csenge Advisory Group’s Barclays BCS Stock Holding History

Csenge Advisory Group’s Portfolio BCS Stock Details BCS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$378K	Buy	14,072 +4,054	+40%	+$97.8K	0.02%	544
2026 Q1	$212K	Buy	+10,018	New	+$244K	0.01%	692
2018 Q4	–	Sell	-217	Closed	-$1K	–	329
2018 Q3	$1K	Buy	+217	New	+$2.01K	﹤0.01%	833

Other funds holding BCS

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Natixis Advisors Boston, Massachusetts $88.9B AUM 38.03% 1-Year Est. Return

Jones Financial Companies Des Peres, Missouri $250B AUM 21.32% 1-Year Est. Return

Csenge Advisory Group's BCS Position: Q2 2026 in Review

Csenge Advisory Group increased its Barclays (BCS) stake by 40% in Q2 2026, buying an estimated $97.8K and bringing the position to 14,072 shares worth $378K. The position accounts for 0.02% of the portfolio, ranked #544.

Csenge Advisory Group first reported a position in BCS in Q3 2018 and has held it in 3 quarters since. 557 funds tracked by Wall St. Rank hold BCS as of Q2 2026.

Csenge Advisory Group held 14,072 shares of Barclays worth $378K as of Q2 2026.
Csenge Advisory Group bought 4,054 Barclays shares in Q2 2026, an estimated $97.8K.
Barclays made up 0.02% of Csenge Advisory Group's portfolio in Q2 2026, its #544 holding.
Csenge Advisory Group first reported a position in Barclays in Q3 2018 and has held it in 3 quarters since.
557 funds tracked by Wall St. Rank held Barclays as of Q2 2026.

Based on Csenge Advisory Group's 13F filing for Q2 2026, filed 10 Aug 2026.